ATRA Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 107760 min ago

@ $0.771

Wydano: 14 vas. 2024 @ 20:55

Zwrot: -9.47%

Poprzedni sygnał: vas. 13 - 22:34

Poprzedni sygnał: Sprzedaż

Zwrot: -0.05 %

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 17:56):

Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States...

Stats
Dzisiejszy wolumen	373 618
Średni wolumen	2.69M
Kapitalizacja rynkowa	83.32M
EPS	$0 ( 2024-03-27 )
Następna data zysków	( $-0.370 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.270
ATR14	$0.00900 (1.29%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-31	Fust Matthew K	Buy	150 000	Common Stock
2024-03-31	Heiden William K	Buy	150 000	Common Stock
2024-03-31	Roncarolo Maria Grazia	Buy	150 000	Common Stock
2024-03-31	Gallagher Carol Giltner	Buy	150 000	Common Stock
2024-03-31	Mallik Ameet	Buy	150 000	Common Stock

INSIDER POWER
70.32
Last 100 transactions
Buy: 8 350 944 \| Sell: 2 074 393

Wolumen Korelacja

Długi: -0.17 (neutral)

Krótki: -0.92 (very strong negative)

Signal:(47.309) Neutral

Atara Biotherapeutics Inc Korelacja

10 Najbardziej pozytywne korelacje
SRTS	0.965
CDXS	0.964
LGHL	0.959
ZD	0.957
ZYNE	0.952
RKDA	0.95
ATER	0.949
HNNA	0.948
NMTR	0.948
DYNT	0.946

10 Najbardziej negatywne korelacje
MCAA	-0.951
MSDA	-0.949
CITE	-0.945
DHAC	-0.944
AHRN	-0.942
LEGA	-0.942
ADAL	-0.942
FTAA	-0.94
PFTA	-0.939
ZING	-0.939

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Atara Biotherapeutics Inc Korelacja - Waluta/Towar

-0.09
( neutral )

-0.21
( neutral )

0.00
( neutral )

0.44
( neutral )

Atara Biotherapeutics Inc Finanse

Annual	2023
Przychody:	$8.57M
Zysk brutto:	$-313 000 (-3.65 %)
EPS:	$-2.61

FY	2023
Przychody:	$8.57M
Zysk brutto:	$-313 000 (-3.65 %)
EPS:	$-2.61

FY	2022
Przychody:	$63.57M
Zysk brutto:	$49.01M (77.08 %)
EPS:	$-2.24

FY	2021
Przychody:	$20.34M
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-3.63

Financial Reports:

No articles found.

Atara Biotherapeutics Inc

Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company is also developing next-generation CAR T immunotherapies for patients with hematologic malignancies and solid tumors, including ATA2271 and ATA3271 for mesothelin; and ATA2431 and ATA3219 for B-cell malignancies, as well as ATA188 for the treatment of multiple sclerosis. In addition, it develops ATA368 program for patients with human papillomavirus associated cancers. Atara Biotherapeutics, Inc. has a license agreement with Memorial Sloan Kettering Cancer Center; license, and research and development collaboration agreement with QIMR Berghofer Medical Research Institute; and strategic collaboration with H. Lee Moffitt Cancer Center, as well as Bayer AG for mesothelin-targeted CAR T-cell therapies for solid tumors. The company was incorporated in 2012 and is headquartered in South San Francisco, California.